Evidence map›Paper›PMID 24231768›Full record

ArticleCell cycle (Georgetown, Tex.)2014

miR-22 in tumorigenesis.

Su Jung Song, Pier Paolo Pandolfi

Abstract readEditorialComment
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Aberrant miRNAs expressed in HER-2 negative breast cancers patient.Journal of experimental & clinical cancer research : CR · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Decreased microRNA-22 is associated with poor prognosis in cervical cancer.International journal of clinical and experimental pathology · 2017
    Article
  16. An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Su Jung SongCancer Genetics Program; Beth Israel Deaconess Cancer Center; Department of Medicine and Pathology; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston, MA USA.
Pier Paolo PandolfiCancer Genetics Program; Beth Israel Deaconess Cancer Center; Department of Medicine and Pathology; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston, MA USA.

Funding

PTEN IN ONTOGENESIS AND TUMOR SUPPRESSIONR01CA082328 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PANDOLFI, PIER PAOLO · 1999 to 2015
$5.3M
NCI NIH HHS R01 CA082328
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chromatin Assembly and DisassemblyEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticNeoplasm MetastasisAnimalsBreast NeoplasmsHumansMicroRNAsNeoplastic Stem CellsMicroRNAscancerepigeneticsmetastasismicroRNA

Identifiers

PMID24231768
PMCPMC3925720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.